The FDA Task Force is charged with creating a more efficient and timely approval process for new and non-proprietary radiotracers and radiotherapeutics by the U.S. Food and Drug Administration.
Munir Ghesani, MD, FACNM, FSNMMI | Board Liaison |
Christina M. Arenas, JD, MPH | Liaison |
Virginia Pappas, CAE,FSNMMI(H), FSNMM | Liaison |